Skip to main content
In stock | Targeted Therapy (Antibody)

Cetuximab

Oncology Type Solid Tumour
Drug Class / Mechanism Anti-EGFR mAb
No Image
Description

Cetuximab is classified as an Anti-EGFR mAb, sourced for use within our Targeted Therapy (Antibody) portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic Category Targeted Therapy (Antibody)
Oncology Type Solid Tumour

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3